文献速递乳房整形与再造创面修复

三维打印序贯双药释放补片对大鼠硅胶假体周围包膜形成的影响

The Effect of 3-Dimensional-Printed Sequential Dual Drug-Releasing Patch on the Capsule Formation Around the Silicone Implant in a Rat Model.
PubMed 文献 · Aesthet Surg J · 2024-01-01

本研究在大鼠硅胶假体模型中评估三维打印双药释放补片的可行性,该补片可时空可控地释放抗生素和免疫抑制剂。组织学与免疫组化分析显示,与单纯细菌接种组相比,抗生素补片组和双药补片组包膜更薄、肌成纤维细胞活性和炎症更低,且双药补片效果更明显。

要点

  • 双药补片序贯释放庆大霉素和曲安奈德,释放曲线不同。
  • 双药补片组包膜更薄、肌成纤维细胞活性和炎症低于细菌接种组。
  • 双药补片效果优于单抗生素补片,提示预防包膜挛缩潜力。

核心结论

  • 三维打印双药释放补片在大鼠硅胶乳房重建模型中有效减少炎症和包膜形成。
  • 双药补片的有益效果优于单抗生素补片,提示其作为预防包膜挛缩新方法的治疗潜力,同时减少全身副作用担忧。

研究设计与样本

  • 在大鼠硅胶假体模型中评估用组织来源生物材料墨水三维打印的双药释放补片的功效。
  • 分组包括:仅假体组(n=10);假体加细菌接种组(n=14);假体、细菌接种加载庆大霉素补片置于假体腹侧组(n=10);假体、细菌接种加载庆大霉素和曲安奈德补片组(n=9)。
  • 植入后8周进行组织学和免疫组化分析。

主要发现

  • 两种药物从双药释放补片中序贯释放,并表现出不同的释放曲线。
  • 与细菌接种组动物相比,抗生素补片组和双药补片组动物包膜更薄、肌成纤维细胞活性和炎症更低,表明组织整合更好、异物反应更少。
  • 双药释放补片的这些效果比单抗生素补片更明显。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Implant-based breast reconstruction is associated with increased risk of early infection and late-stage capsular contracture. OBJECTIVES: We evaluated the feasibility of a dual drug-releasing patch that enabled the controlled delivery of antibiotics and immunosuppressants in a temporally and spatially appropriate manner to the implant site. METHODS: The efficacy of a dual drug-releasing patch, which was 3-dimensional-printed (3D-printed) with tissue-derived biomaterial ink, was evaluated in rats with silicone implants. The groups included implant only (n = 10); implant plus bacterial inoculation (n = 14); implant, bacterial inoculation, and patch loaded with gentamycin placed on the ventral side of the implant (n = 10), and implant, bacterial inoculation, and patch loaded with gentamycin and triamcinolone acetonide (n = 9). Histologic and immunohistochemical analyses were performed 8 weeks after implantation. RESULTS: The 2 drugs were sequentially released from the dual drug-releasing patch and exhibited different release profiles. Compared to the animals with bacterial inoculation, those with the antibiotic-only and the dual drug-releasing patch exhibited thinner capsules and lower myofibroblast activity and inflammation, indicating better tissue integration and less foreign body response. These effects were more pronounced with the dual drug-releasing patch than with the antibiotic-only patch. CONCLUSIONS: The 3D-printed dual drug-releasing patch effectively reduced inflammation and capsule formation in a rat model of silicone breast reconstruction. The beneficial effect of the dual drug-releasing patch was better than that of the antibiotic-only patch, indicating its therapeutic potential as a novel approach to preventing capsular contracture while reducing concerns of systemic side effects.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Kim HB, Jo Y, Woo SH, et al. The Effect of 3-Dimensional-Printed Sequential Dual Drug-Releasing Patch on the Capsule Formation Around the Silicone Implant in a Rat Model. Aesthet Surg J. 2024. PMID: 38330289. doi:10.1093/asj/sjae008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。